Cardinal Health Inc. (CAH)
NYSE: CAHHealth CareOther PharmaceuticalsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CAH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $53.76B
- P/E (TTM)
- 32.11
- Forward P/E
- 16.52
- EPS (TTM)
- $7.23
- Dividend yield
- 0.88% ($2.05)
- Ex-dividend date
- Oct 1, 2026
- 52-week range
- 151.87 – 258.30
- Day range
- 230.62 – 235.97
- Volume / Avg
- 1.10M / 1.93M
- Beta
- —
- Shares outstanding
- 231.56M
- Next earnings
- Nov 5, 2026
52-week range
CAH stock today
Shares of Cardinal Health (CAH) finished lower on Oct 7 at $232.16, a drop of 0.55% or $1.28 per share, versus the S&P 500's 0.22% decline. At this level, CAH sits in the middle of its 52-week range of $151.87 to $258.30: 10.1% below the high, set on Aug 11, 2026 and 52.9% above the low. CAH is up 13.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 48.2%.
At 32.1x trailing earnings, Cardinal Health trades above the peer-group median of 23.6x. Its forward P/E of 16.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Cardinal Health's next earnings report is expected on Nov 5, 2026. Cardinal Health pays an annual dividend of $2.05 per share, a 0.88% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Cardinal Health
Company profileCardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Jason M. Hollar
- Headquarters
- Dublin, OH
- Employees
- 58,788
- Website
- cardinalhealth.com
Financial highlights
Full financialsIn fiscal 2026, Cardinal Health generated $254.25 billion in revenue, up 14.2% from fiscal 2025. Net income was $1.71 billion (+9.8% year over year), for a net margin of 0.7% versus a median of 0.4% in the prior 5 years. Gross margin was 3.8% (up from 3.7%) and operating margin 1.0%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| Growth | +14.23% | -1.87% | +10.66% | +13.04% | +11.61% |
| Net income | $1.71B | $1.56B | $852.00M | $330.00M | $-938.00M |
| EPS (diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
Analyst forecast
ForecastConsensus (17 analysts)
buy
Avg. price target
$270.33+16.44%
- Strong buy 3
- Buy 11
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $2.92
- Last reported (Q2 2026)
- Feb 5, 2026
- EPS actual vs est.
- $1.97 vs —
Dividends
Dividend history- Annual dividend
- $2.05
- Dividend yield
- 0.88%
- Last payment
- $0.516
- Ex-dividend date
- Oct 1, 2026
CAH news
All CAH news- Reasons to Retain Cardinal Health Stock in Your Portfolio for NowNasdaqCAH, MMSI, WST, GMED
- CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?NasdaqCVS, UNH, CAH
- Cardinal Health (CAH) Outperforms Broader Market: What You Need to KnowNasdaq
- Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexNasdaqBDX, CAH, MCK, MMSI
- McKesson, Cardinal Health extend distribution agreements with CVS HealthSeeking AlphaCAH, MCK, CVS
- 5 Medical Dental Supply Stocks to Watch as Industry Prospects ImproveNasdaqMCK, BDX, CAH, MMSI
- Cardinal Health Extends Pharmaceutical Distribution Agreement With CVS HealthNasdaqCAH, CVS
- Cardinal Health: I'm Still Buying After Checking The NumbersSeeking Alpha
Cardinal Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CORCencora Inc. | 317.25 | +0.28% | $60.54B | vs CAH |
| MCKMcKesson Corporation | 910.33 | -1.23% | $106.14B | vs CAH |
| HLFHerbalife Ltd. | 12.65 | +0.56% | $1.31B | vs CAH |
| NUSNu Skin Enterprises Inc. | 4.80 | +1.27% | $233.65M | vs CAH |
| ZSTKZeroStack Corp. | 4.77 | +0.42% | $103.97M | vs CAH |
| ESYNEnerSyn Global Inc. | 2.06 | -1.90% | $61.24M | vs CAH |
| COSMCosmos Health Inc. | 0.3209 | +0.44% | $32.29M | vs CAH |
| MEDSDataMeds AI Inc. | 2.88 | -6.19% | $8.16M | vs CAH |
Indexes, lists and sector
Index membership
Appears in lists
Cardinal Health stock FAQ
What is Cardinal Health's stock price today?
CAH last traded at $232.16 as of Oct 7, 4:00 PM EDT, down 0.55% on the day. Prices are delayed at least 15 minutes.
Does Cardinal Health pay a dividend?
Yes. Cardinal Health pays $2.05 per share annually, a 0.88% yield. The most recent dividend of $0.516 had an ex-dividend date of Oct 1, 2026.
When is Cardinal Health's next earnings date?
Cardinal Health is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $2.92.
What is CAH's P/E ratio?
CAH trades at a trailing P/E ratio of 32.11 and a forward P/E of 16.52, compared with a median of 23.6 for its closest peers.
Is Cardinal Health in the S&P 500?
Yes. Cardinal Health (CAH) is a constituent of the S&P 500 index.
Who is Cardinal Health's CEO?
Mr. Jason M. Hollar is the chief executive officer of Cardinal Health Inc., which has about 58,788 employees.
Has CAH ever split its stock?
Yes. The most recent CAH stock split was a 3-for-2 split on Apr 23, 2001, one of 9 splits on record.